Daily Summary of Health · Live edition, updated continuouslyWednesday 18 November 2026 · UTC

Latest Health News Today: 18 November 2026

FDA rejects Summit drug and approves rare-disease treatment as measles returns to the US

The FDA disclosed reasons for rejecting a Summit drug and the Trump administration withdrew Heidi Overton's nomination to lead the agency, while the FDA also approved a new treatment for infantile-onset Niemann-Pick disease type C. The Pan American Health Organization declared measles resurgent in the United States, ending 26 years of US elimination status.

A national trauma-center analysis found injured e-scooter riders had a higher risk of serious head or neck injury than injured bicycle riders.

Illustration of the day's news: FDA rejects Summit drug and approves rare-disease treatment as measles returns to the USIllustration
DS
Daily Summary Of Editors · How we summarise
23 stories27 sources
Image from Illustration: FDA discloses reasons for rejecting Summit drugIllustration
01First reported

FDA discloses reasons for rejecting Summit drug

The FDA disclosed reasons for rejecting a Summit drug. The Trump administration also withdrew its nomination of Heidi Overton to be FDA commissioner. The disclosure concerns Summit's product, and the withdrawal concerns the agency's leadership.

Image from Illustration: Lucy Letby expert witness was barred from treating patients during trialIllustration
02First reported

Lucy Letby expert witness was barred from treating patients during trial

A senior doctor whose evidence helped convict Lucy Letby was barred from treating patients during her trial, a Guardian investigation found. Prof Peter Hindmarsh, a child hormone specialist, was excluded from clinical practice by University College London Hospitals in March 2023 over concerns his insulin advice was unsafe for children. Jurors and Letby's defence were not told of the bar, which could have allowed them to challenge his evidence.

Image from Illustration: US loses measles elimination status as Paho declares resurgent spreadIllustration
03First reported

US loses measles elimination status as Paho declares resurgent spread

The Pan American Health Organization declared measles resurgent in the United States, Bolivia and Mexico, ending 26 years of US measles elimination status. The loss follows the worst US outbreak since 1991 and has intensified calls for Health Secretary Robert F. Kennedy Jr. to resign, including from Republican Sen. Bill Cassidy. Public health leaders described the loss as significant damage to a hard-won public health victory.

Developing storyUS loses measles elimination statusFull timeline →
Image from Illustration: Cooper pledges care teams for 500,000 vulnerable in EnglandIllustration
04First reported

Cooper pledges care teams for 500,000 vulnerable in England

Health Secretary Yvette Cooper said new joint NHS and social care teams will support about 500,000 vulnerable people in England by next April, including elderly people, care home residents, people with dementia and those near end of life. Cooper described the new support as a downpayment on a national care service, saying the teams will eventually cover about 2 million people and cut 4.3 million hospital bed days.

Image from Illustration: Semaglutide may improve eating disorder symptoms and body image in obesity treatmentIllustration
05First reported

Semaglutide may improve eating disorder symptoms and body image in obesity treatment

A University of Pennsylvania study of 120 adults seeking obesity treatment found semaglutide 2.4 mg, with a structured lifestyle intervention, produced greater weight loss and improvements in eating disorder symptoms, loss-of-control eating and body image than placebo. After 60 weeks, semaglutide users lost about 15% of body weight, compared with about 3% for placebo. The results suggest the drug may also benefit psychological eating measures.

Image from Illustration: 40Hz light and sound goggles slow decline in mild Alzheimer'sIllustration
06First reported

40Hz light and sound goggles slow decline in mild Alzheimer's

Cognito Therapeutics said its HOPE trial found that 40Hz light and sound stimulation slowed decline in daily function and cognition among 395 people with mild Alzheimer's disease. The overall study did not meet its primary endpoint, and the 268-person moderate group showed no clinical benefit. Cognito will pursue FDA approval for its Spectris goggles, with stronger effects in mild patients who used the device at least 70% of the intended time.

Image from Illustration: NHS in England records 3,029 staff snooping incidents in five yearsIllustration
07First reported

NHS in England records 3,029 staff snooping incidents in five years

The NHS in England recorded 3,029 incidents of staff inappropriately accessing patient records over the last five years, according to freedom of information figures. Campaign groups and regulators called the cases deeply concerning, saying they distress patients and erode trust. Only 79 of 143 acute hospital and ambulance trusts provided precise data, and the Information Commissioner's Office chief executive has demanded a crackdown.

Image from Illustration: Appetite-suppressing drugs linked to unrecognized calorie and nutrient shortfallsIllustration
08First reported

Appetite-suppressing drugs linked to unrecognized calorie and nutrient shortfalls

A small exploratory study of 14 patients in England prescribed appetite-suppressing drugs such as Wegovy and Mounjaro found average daily energy intake of 1,231 kcal, 58.5% of estimated requirements. More than three-quarters fell below two-thirds of reference intakes for fiber and vitamin D, and all consumed less than 400g of fruit and vegetables. Researchers said awareness of the risk was low and clinical nutritional guidance was limited.

Image from Illustration: Pill that mimics Viagra may slow early Alzheimer's decline by 31%Illustration
09First reported

Pill that mimics Viagra may slow early Alzheimer's decline by 31%

AR1001, a phosphodiesterase-5 inhibitor in the same family as Viagra, slowed cognitive decline by 31% in a stage three trial of 604 people with early Alzheimer's who were not taking other Alzheimer's drugs. The drug, made by AriBio, was tested in 13 countries, including the UK. In a wider group taking other Alzheimer's medications, the benefit was not statistically significant.

Image from Illustration: Beer and spirits linked to acute kidney injury risk, study findsIllustration
10First reported

Beer and spirits linked to acute kidney injury risk, study finds

A 14 year UK Biobank study by Anglia Ruskin University linked beer and spirits to higher acute kidney injury risk, while wine under 14 units a week appeared protective. Nine units of spirits weekly were associated with 26% higher risk than one unit, and 24 units of beer weekly with 15% higher risk than three units. Researchers said the relationship was associative, not causal, and reopened debate over wine's health benefits.

Image from Illustration: ECDC warns Europe risks pre-antibiotic era as superbugs riseIllustration
11First reported

ECDC warns Europe risks pre-antibiotic era as superbugs rise

The ECDC warned that antimicrobial resistance remains a major threat, with over 35,000 deaths yearly in the EU, Iceland, Liechtenstein and Norway. It said Europe could return to a pre-antibiotic era without effective antibiotics, making organ transplantation, chemotherapy and intensive care difficult. Antibiotic-resistant E. coli incidence rose 16.4% from 2019 to 2025, against a 10% reduction target.

Image from Illustration: Nasal mRNA drops improve memory in aged mice and prevent loss in Alzheimer's modelIllustration
12First reported

Nasal mRNA drops improve memory in aged mice and prevent loss in Alzheimer's model

University of Sydney researchers developed experimental nose drops that deliver mRNA in lipid nanoparticles to make brain-derived neurotrophic factor, a protein linked to memory. In aged mice, the drops significantly improved learning and memory, with treated animals performing like young mice in standardized tests. The team also reported preventing memory loss in a mouse model of Alzheimer's disease.

Image from Illustration: Chronic loneliness linked to 38% higher dementia riskIllustration
13First reported

Chronic loneliness linked to 38% higher dementia risk

A 30 year study by Bordeaux researchers of 3,777 French adults aged 65 and over found chronic loneliness was associated with a 38% higher risk of dementia compared with never feeling lonely. Occasional loneliness showed no significant association. Researchers said the distinction matters because most people experience loneliness at some point, but persistent loneliness may increase cognitive risk.

Image from Illustration: Injured e-scooter riders face higher head and neck risk than cyclistsIllustration
14First reported

Injured e-scooter riders face higher head and neck risk than cyclists

A national trauma-center analysis of 47,102 adults treated in 2023 and 2024 found injured e-scooter riders had a higher risk of serious head or neck injury than injured bicycle riders, though their injuries were less severe overall. Helmet use was uncommon, especially among e-scooter riders, and alcohol at or above the 0.08% driving threshold was recorded more often among e-scooter and e-bike riders than bicycle riders.

Image from Illustration: Mayo Clinic identifies BRCA2 variants tied to moderate breast cancer riskIllustration
15First reported

Mayo Clinic identifies BRCA2 variants tied to moderate breast cancer risk

Mayo Clinic researchers identified 70 BRCA2 gene variants that partially disrupt the gene and are linked to a moderate breast cancer risk. People who inherit these hypomorphic variants are estimated to have a 20% to 25% lifetime risk, compared with 50% to 70% for more common harmful BRCA2 variants. The findings could help tailor screening and prevention, and some associated tumors may respond to PARP inhibitors.

Image from Illustration: Large and very small waist sizes linked to higher death risk, study findsIllustration
16First reported

Large and very small waist sizes linked to higher death risk, study finds

A South Korean study of more than 17 million adults found both large and very small waist sizes were associated with higher all-cause mortality across body weights. The Journal of Epidemiology & Community Health paper reported the lowest risk at waist sizes of 80 to 94 cm for men and 75 to 89 cm for women. The findings suggested a slimmer waist may reduce risk more than weight loss alone in overweight people.

Image from Illustration: Two patients hospitalized with psychosis or mania after stopping GLP-1 drugsIllustration
17First reported

Two patients hospitalized with psychosis or mania after stopping GLP-1 drugs

Two case reports described men hospitalized with psychosis or mania after stopping tirzepatide, a GLP-1 drug. One man, 61, had confusion, hallucinations and Cotard delusion after stopping in August 2025; a second man, 52, had a manic episode after stopping the month before. The authors said discontinuation may contribute to acute mood or psychotic symptoms in some patients at risk, but the cases do not prove causation.

Image from Illustration: FDA clears first pearl shell bone graft material for US saleIllustration
18First reported

FDA clears first pearl shell bone graft material for US sale

The FDA gave 510(k) clearance to PearlBone Putty 1600, a bone repair material made from pearl shells. It is the first replacement bone graft material made from nacre, the mineral layer inside oyster shells, and can now be sold in the US for bone fractures. Researchers said a chemical process converts nacre's calcium carbonate into calcium phosphate of human bone in 24 hours. Grafts cannot be intrinsic to bone stability.

Image from Illustration: UK watchdog bans five Voy testosterone test advertsIllustration
19First reported

UK watchdog bans five Voy testosterone test adverts

The Advertising Standards Authority banned five adverts by online healthcare provider Voy for promoting at-home testosterone blood tests with misleading claims. The three posters and two Facebook ads linked common symptoms such as irritability, fatigue, low energy and mood changes to low testosterone, and one claimed low testosterone sneaks up on 1 in 4 men over 30. Voy said it had withdrawn the adverts and would not run them again.

Image from Illustration: UK study of 300,000 young people to check social media ban's effectIllustration
20First reported

UK study of 300,000 young people to check social media ban's effect

More than 300,000 young people in Britain will join ten projects studying how a social media ban for under-16s, starting in spring 2027, may affect mental health. The Wellcome Trust-funded work will use wearables, smartphones, digital diaries and surveys to track phone habits, wellbeing and ways around restrictions. Early results are expected before the ban and may inform UK and international online safety policies.

Image from Illustration: Keto review: weight and fat fall, but muscle loss may be water lossIllustration
21First reported

Keto review: weight and fat fall, but muscle loss may be water loss

A review of 50 clinical trials found that ketogenic diets reduced body weight and fat mass in most studies while generally preserving maximal strength and power. Pooled estimates suggested less favorable changes in measured fat-free mass, but an exploratory analysis indicated that glycogen and water depletion may partly explain those differences. The review noted that actual muscle tissue loss remains possible.

Image from Illustration: White House pulls Heidi Overton's FDA nominationIllustration
22First reported

White House pulls Heidi Overton's FDA nomination

The Trump administration is withdrawing its nominee to lead the Food and Drug Administration, Heidi Overton, according to a White House official and a source close to Overton. Overton, a preventive care doctor who previously served in the Trump White House, was expected to face a Senate health panel vote on Wednesday. The move follows concerns that she lacked sufficient support from Republicans on that panel.

Developing storyWhite House withdraws FDA nominee OvertonFull timeline →
Image from Illustration: Study examines global malnutrition burden across wealth, geography and sexIllustration
23First reported

Study examines global malnutrition burden across wealth, geography and sex

A study of 283,426 adults in 80 countries and territories found that nearly six in ten were underweight, overweight or obese, a pattern researchers call the double burden of malnutrition. The prevalence was generally higher among women and in higher income countries, with the highest regional rates in Oceania and more than 93% in American Samoa. The findings, published in Scientific Reports, use WHO STEPS survey data from 2004 to 2024.